166
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Cardiac structure and function in a mouse model of uraemia without hypertension

, , , &
Pages 660-666 | Received 05 Jan 2008, Accepted 02 Mar 2008, Published online: 08 Jul 2009

References

  • Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–305
  • Foley R. N., Murray A. M., Li S., Herzog C. A., McBean A. M., Eggers P. W., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489–95
  • United States Renal Data System (USRDS). Annual Data Report 2004. Available at: www.usrds.org.
  • Tyralla K., Amann K. Morphology of the heart and arteries in renal failure. Kidney Int 2003; 63(Suppl 84)S80–3
  • Stefanski A., Schmidt K. G., Waldherr R., Ritz E. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 1996; 50: 1321–6
  • Mitsnefes M. M., Kimball T. R., Border W. L., Witt S. A., Glascock B. J., Khoury P. R., et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 2004; 65: 1461–6
  • Levin A., Singer J., Thompson C. R., Ross H., Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347–54
  • Amann K., Wanner C., Ritz E. Cross‐talk between the kidney and the cardiovascular system. J Am Soc Nephrol 2006; 17: 2112–19
  • Amann K., Breitbach M., Ritz E., Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018–22
  • Perneger T. V., Whelton P. K., Klag M. J. History of hypertension in patients treated for end‐stage renal disease. J Hypertens 1997; 15: 451–6
  • Ayus J. C., Mizani M. R., Achinger S. G., Thadhani R., Go A. S., Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 2005; 16: 2778–88
  • Bro S., Bentzon J. F., Falk E., Andersen C. B., Olgaard K., Nielsen L. B. Chronic renal failure accelerates atherogenesis in apolipoprotein e‐deficient mice. J Am Soc Nephrol 2003; 14: 2466–74
  • Buzello M., Tornig J., Faulhaber J., Ehmke H., Ritz E., Amann K. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14: 311–16
  • Massy Z. A., Ivanovski O., Nguyen‐Khoa T., Angulo J., Szumilak D., Mothu N., et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109–16
  • Bro S., Moeller F., Andersen C. B., Olgaard K., Nielsen L. B. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein‐E‐deficient mice. J Am Soc Nephrol 2004; 15: 1495–503
  • Bro S., Borup R., Andersen C. B., Moeller F., Olgaard K., Nielsen L. B. Uremia‐specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E‐deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 570–5
  • Bro S., Binder C. J., Witztum J. L., Olgaard K., Nielsen L. B. Inhibition of the renin‐angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E‐deficient mice. Arterioscler Thromb Vasc Biol 2007; 27: 1080–6
  • London G. M., Pannier B., Guerin A. P., Marchais S. J., Safar M. E., Cuche J. L. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end‐stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994; 90: 2786–96
  • Krege J. H., Hodgin J. B., Hagaman J. R., Smithies O. A noninvasive computerized tail‐cuff system for measuring blood pressure in mice. Hypertension 1995; 25: 1111–15
  • Bollano E. Sahlgrenska Academy, Goteborg University, Sweden [Doctoral Thesis]. 2001
  • Nielsen L. B., Bartels E. D., Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002; 277: 27014–20
  • Puchtler H., Waldrop F. S., Valentine L. S. Polarization microscopic studies of connective tissue stained with picro‐sirius red FBA. Beitr Pathol 1973; 150: 174–87
  • Ma L. J., Fogo A. B. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int 2003; 64: 350–5
  • Kren S., Hostetter T. H. The course of the remnant kidney model in mice. Kidney Int 1999; 56: 333–7
  • Kennedy D. J., Elkareh J., Shidyak A., Shapiro A. P., Smaili S., Mutgi K., et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 2008; 294: F450–4
  • Kennedy D. J., Vetteth S., Periyasamy S. M., Kanj M., Fedorova L., Khouri S., et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006; 47: 488–95
  • Rambausek M., Ritz E., Mall G., Mehls O., Katus H. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 1985; 28: 775–82
  • Litwin S. E., Katz S. E., Morgan J. P., Douglas P. S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994; 89: 345–54
  • Tanaka N., Dalton N., Mao L., Rockman H. A., Peterson K. L., Gottshall K. R., et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 1996; 94: 1109–17
  • Pollick C., Hale S. L., Kloner R. A. Echocardiographic and cardiac Doppler assessment of mice. J Am Soc Echocardiogr 1995; 8: 602–10
  • Manning W. J., Wei J. Y., Katz S. E., Litwin S. E., Douglas P. S. In vivo assessment of LV mass in mice using high‐frequency cardiac ultrasound: necropsy validation. Am J Physiol 1994; 266: H1672–5
  • Collins K. A., Korcarz C. E., Lang R. M. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 2003; 13: 227–39
  • Christoffersen C., Bollano E., Lindegaard M. L., Bartels E. D., Goetze J. P., Andersen C. B., et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003; 144: 3483–90
  • Dhein S., Rohnert P., Markau S., Kotchi‐Kotchi E., Becker K., Poller U., et al. Cardiac beta‐adrenoceptors in chronic uremia: studies in humans and rats. J Am Coll Cardiol 2000; 36: 608–17
  • Rostand S. G., Drueke T. B. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383–92
  • Brewster U. C., Perazella M. A. The renin‐angiotensin‐aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263–72
  • Wollert K. C., Drexler H. The renin‐angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43: 838–49
  • Gonzalez B. L., Kurnjek M. L., Muller A., Basso N. Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat. Am J Hypertens 2000; 13: 1301–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.